Summarized by Masters of Longevity from Longevity Technology.
A short news piece about a collaboration exploring a two-step pathway that pairs a quick digital memory screen with a confirmatory blood biomarker test to improve early neurodegeneration detection and triage for clinical and research use.
Key Takeaways
- Combining a quick digital cognitive screen with a blood-based biomarker can create a two-step pathway for earlier neurodegeneration detection.
- Using PREMAZ as an accessible front end can triage people for confirmatory biomarker testing with Amprion’s assays.
- Successful implementation could enable earlier intervention and improve patient selection for trials and therapies.
